Erratum. XXXX after Total Hip Arthroplasty Diagnosed by Enhanced Computed Tomography:Comparison of Selective Thromboprophylaxis and No Thromboprophylaxis.

@entity1 @entity417 @entity548 @entity409 @entity572 @entity1211 @entity2120 @entity570
UNASSIGNED: @entity572 ( @entity572 ) is the most effective treatment for advanced or end-stage @entity570 . However, @entity1211 ( @entity1211 ) remains one of its unresolved complications. We reviewed the records of 322 @entity1 undergoing primary @entity572 and investigated the efficacy of anticoagulant prophylaxis for @entity1211 . Our study cohort consisted of 60 @entity1 who received no anticoagulants, 100 @entity1 who received a factor Xa inhibitor (fondaparinux), 100 @entity1 who received low molecular weight heparin ( @entity2120 ), and 62 @entity1 who selectively received no anticoagulant prophylaxis due to perioperative @entity548 , weight, and/or hemoglobin concentration. Enhanced 64-slice multidetector row computed tomography was performed postoperatively for 7 days in all cases. The incidence of @entity1211 in the four groups was 15%, 9.0%, 6.0%, and 6.4%, respectively. The incidence of @entity1211 was significantly lower in the groups receiving anticoagulant prophylaxis and the group selectively receiving no anticoagulant prophylaxis than in the group receiving no anticoagulants. Complications of fondaparinux therapy included @entity409 in 4 cases (4.0%), minor @entity548 in 2 cases (2.0%), persistent wound drainage in 3 cases (3.0%), and eruption in 1 case (1.0%). The complications of @entity2120 therapy were persistent wound drainage in 1 case (1.0%) and progression of @entity417 in 1 case (1.0%). The incidence of @entity1211 was low in @entity1 who selectively received no anticoagulant prophylaxis, so we conclude that anticoagulant prophylaxis should be used selectively in @entity572 cases.
